This week, Anthem announced an agreement to buy Cigna for $54.2 billion and Aetna announced earlier this month it plans to acquire Humana for $37 billion.
“The lack of a competitive health insurance market allows the few remaining companies to exploit their market power, dictate premium increases and pursue corporate policies that are contrary to patient interests,” Steven J. Stack, MD, president of the AMA, said in the statement. “Health insurers have been unable to demonstrate that mergers create efficiency and lower health insurance premiums.”
The statement cites an AMA study of the 2008 merger between UnitedHealth Group and Sierra Health Services that shows premiums jumped 14 percent after the merger. The AMA also points to an analysis that shows the Anthem-Cigna merger would be anticompetitive in the commercial, combined markets — which include HMO, PPO and POS plans — in nine out of 14 states, based on federal regulations.
“To give commercial health insurers virtually unlimited power to exert control over an issue as significant and sensitive as patient healthcare is bad for patients and not good for the nation’s healthcare system. The U.S. Department of Justice has recognized that patient interests can be harmed when a big insurer has a stranglehold on a local market,” the statement reads.
More articles on payer issues:
Humana hit with investor class-action lawsuit over Aetna deal
Health insurers in the news: 2 Weeks in review July 10-23
BCBS of Georgia accused of fraudulently overcharging customers
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
